SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-013213
Filing Date
2024-02-09
Accepted
2024-02-09 17:00:09
Documents
1
Period of Report
2024-02-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm245346-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm245346-2_4seq1.xml 4 5287
  Complete submission text file 0001104659-24-013213.txt   6932
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Issuer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
David Glenn (Reporting) CIK: 0001606256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36410 | Film No.: 24615904